00:00Novo Nordisk is rolling out the first ever GLP-1 weight loss pill in the U.S., marking
00:05a major shift in obesity treatment.
00:08The daily oral drug, called the WegoV pill, is priced well below injectable competitors,
00:14with cash prices ranging from $149 to $299 a month, depending on the dose.
00:20It will be available at more than 70,000 pharmacies, major retailers, telehealth platforms, and
00:27through a direct-to-consumer, government-backed website.
00:30The FDA approved the pill for both weight loss and for reducing major cardiovascular risks
00:34in adults with obesity and heart disease.
Comments